CINECA IRIS Institutional Research Information System

PETRINI, MARIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 51.781
AS - Asia 23.286
EU - Europa 20.492
SA - Sud America 3.285
AF - Africa 928
OC - Oceania 59
Continente sconosciuto - Info sul continente non disponibili 20
Totale 99.851
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 48.036
CN - Cina 7.022
SG - Singapore 6.913
IT - Italia 6.549
SE - Svezia 3.618
HK - Hong Kong 3.594
CA - Canada 3.426
BR - Brasile 2.765
DE - Germania 2.032
VN - Vietnam 1.970
BG - Bulgaria 1.640
GB - Regno Unito 1.210
TR - Turchia 1.174
PL - Polonia 1.057
FI - Finlandia 861
UA - Ucraina 840
FR - Francia 813
RU - Federazione Russa 769
KR - Corea 564
IN - India 496
JP - Giappone 392
CH - Svizzera 350
CI - Costa d'Avorio 329
BD - Bangladesh 222
AT - Austria 197
IQ - Iraq 152
AR - Argentina 151
BE - Belgio 149
MX - Messico 143
SN - Senegal 127
PK - Pakistan 108
ZA - Sudafrica 99
NG - Nigeria 94
SA - Arabia Saudita 91
UZ - Uzbekistan 85
ID - Indonesia 79
NL - Olanda 77
EC - Ecuador 75
VE - Venezuela 66
CO - Colombia 62
ES - Italia 61
MA - Marocco 56
EG - Egitto 52
KE - Kenya 50
AU - Australia 45
CL - Cile 44
AE - Emirati Arabi Uniti 38
IL - Israele 38
PH - Filippine 37
PY - Paraguay 37
JM - Giamaica 34
MY - Malesia 34
UY - Uruguay 34
JO - Giordania 33
CZ - Repubblica Ceca 32
LT - Lituania 29
IE - Irlanda 27
BJ - Benin 25
TN - Tunisia 25
AZ - Azerbaigian 24
CR - Costa Rica 24
PE - Perù 24
QA - Qatar 24
NP - Nepal 21
PT - Portogallo 21
TH - Thailandia 21
OM - Oman 20
EE - Estonia 19
HN - Honduras 19
KZ - Kazakistan 19
BO - Bolivia 18
GR - Grecia 18
DZ - Algeria 16
IR - Iran 16
PS - Palestinian Territory 16
DK - Danimarca 15
HU - Ungheria 15
DO - Repubblica Dominicana 13
ET - Etiopia 13
RO - Romania 13
SI - Slovenia 13
TT - Trinidad e Tobago 13
EU - Europa 12
NI - Nicaragua 12
AL - Albania 11
BY - Bielorussia 11
PA - Panama 11
BB - Barbados 10
CY - Cipro 10
LB - Libano 10
CG - Congo 9
KG - Kirghizistan 9
MD - Moldavia 9
RS - Serbia 9
LV - Lettonia 8
TW - Taiwan 8
AG - Antigua e Barbuda 7
AO - Angola 7
GE - Georgia 7
GY - Guiana 7
Totale 99.710
Salva come PNG Salva come JPEG
Città #
Woodbridge 5.316
Ashburn 4.575
Ann Arbor 4.260
Singapore 3.838
Hong Kong 3.548
Fairfield 3.518
Houston 3.330
Chandler 2.944
Santa Clara 2.545
San Jose 2.376
Serra 2.357
Montreal 2.330
Dallas 1.745
Milan 1.690
Sofia 1.627
Seattle 1.559
Beijing 1.530
Shanghai 1.367
Wilmington 1.259
Cambridge 1.156
Jacksonville 1.120
New York 1.022
Ottawa 955
Boardman 811
Hefei 781
Princeton 760
Izmir 742
Los Angeles 625
Lawrence 620
Medford 581
Lauterbourg 561
Seoul 550
Nanjing 520
Ho Chi Minh City 423
Des Moines 395
Dearborn 379
Tokyo 348
Dong Ket 329
Abidjan 328
Bern 319
Istanbul 310
Florence 299
Hanoi 287
Munich 260
Council Bluffs 257
Buffalo 244
Nanchang 237
Lancaster 228
São Paulo 226
London 206
San Diego 200
Jüchen 197
Redondo Beach 189
Rome 183
Frankfurt am Main 170
Helsinki 170
Vienna 168
Redwood City 159
Boulder 151
Brussels 146
Pisa 141
Bremen 137
Kunming 137
Dakar 127
Columbus 120
The Dalles 120
Orem 117
Shenyang 117
Chicago 107
Hebei 105
Changsha 103
Lagos 91
Ogden 89
Washington 88
Rio de Janeiro 87
Turku 82
Jiaxing 80
Fuzhou 77
Tashkent 77
Westminster 73
Pune 70
Düsseldorf 69
Tianjin 68
Da Nang 67
Dhaka 63
Norwalk 63
Belo Horizonte 62
Falls Church 61
Warsaw 61
Guangzhou 60
Chennai 59
Phoenix 59
Hangzhou 55
Baghdad 52
Nürnberg 52
Quanzhou 52
Porto Alegre 51
Curitiba 47
San Francisco 46
Orange 45
Totale 72.563
Salva come PNG Salva come JPEG
Nome #
EFFICACY AND TOXICITY PROFILES OF LOW-DOSE THALIDOMIDE AS MAINTENANCE THERAPY IN MULTIPLE MYELOMA PATIENTS AFTER DOUBLE OR TRIPLE AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION. 3.413
ROLE OF GENETIC POLYMORPHISMS ON RESPONSE TO R-CHOP REGIMEN IN DIFFUSE LARGE B-CELL LYMPHOMA PATIENTS: AN INTERIM ANALYSIS OF A MULTICENTER PROSPECTIVE PHARMACOGENETIC STUDY 339
1,25(OH)2D3 and TPA in vitro activity on B-CLL. 286
Kinetics of hematogones in bone marrow samples from patients with non-Hodgkin lymphomas treated with rituximab-containing regimens: a flow cytometric study 273
CD57 expression on lymphoma microenvironment as a new prognostic marker related to immune dysfunction 263
How Nanotechnology Can Really Improve the Future of Orthopedic Implants and Scaffolds for Bone Defects 259
B-cell acute lymphoblastic leukemia with t(4;11)(q21;q23) in a young woman: evolution into mixed phenotype acute leukemia with additional chromosomal aberrations in the course of therapy. 258
Is binding of vitamin D binding protein related to cell differentiation? 255
Acute myeloid leukemia and follicular lymphoma after very low dose radioiodine therapy for thyroid diseases 255
Pore Size Distribution and Blend Composition Affect In Vitro Prevascularized Bone Matrix Formation on Poly(Vinyl Alcohol)/Gelatin Sponges 249
Atypical APL including multiple translocations and abnormal response to micronuclei induction test 246
EVALUATION OF RESISTANCE INDEX OF SEVERAL ANTICANCER AGENTS ON PARENTAL AND RESISTANT P-388 CELL LINES 245
Inferential mining for reconstruction of 3D cell structures in Atomic Force Microscopy imaging 242
INDOMETHACIN INHIBITION OF BONE-MARROW GRANULOCYTE RELEASE INTO PERIPHERAL-BLOOD 240
Mesenchymal Stromal Cell Culture and Delivery in Autologous Conditions: A Smart Approach for Orthopedic Applications 240
Evaluation of the MDR1, ABCG2, Topoisomerases IIalpha and GSTpi gene expression in patients affected by aggressive mantle cell lymphoma treated by the R-Hyper-CVAD regimen. Leuk Lymphoma 237
Identification of miRSNPs associated with the risk of multiple myeloma 236
Glycosylation interference on RhoA activation: focus on G-CSF 234
A pleiotropic variant in DNAJB4 is associated with multiple myeloma risk 232
New approaches for imaging and therapy of solid cancer 232
CD45 expression in low-grade B-cell non-Hodgkin's lymphomas 232
Mesenchymal cells inhibit expansion but not cytotoxicity exerted by gamma-delta T cells 232
Plasticity of human dental pulp stromal cells with bioengineering platforms: A versatile tool for regenerative medicine. 232
Bone marrow infiltration in B-cell non-Hodgkin's lymphomas: comparison between flow cytometry and bone marrow biopsy, RECENTI PROGRESSI IN MEDICINA 231
IN THE CHRONIC MYELOID LEUKEMIA THE SALIVARY PROTEOMICS RECAPITULATES SOME ASPECTS OF THE LEUKEMIC STEM CELL. LA CELLULA STAMINALE LEUCEMICA E LA PROTEOMICA SALIVARE: IL MODELLO DELLA LEUCEMIA MIELOIDE CRONICA 230
Bone tissue engineering: Natural origination or synthetic polymeric scaffolds? 228
Acute myeloid leukemia and follicular lymphoma after very low dose radioiodine therapy for thyroid diseases 225
Barium Titanate Nanoparticles: Highly Cytocompatible Dispersions in Glycol-chitosan and Doxorubicin Complexes for Cancer Therapy. 224
Alternating chemotherapy regimen (P-VABEC) for intermediate and high-grade non-Hodgkin's lymphoma of the middle aged and elderly. 224
Identification and purification of mesodermal progenitor cells from human adult bone marrow. 223
Specific integrin expression is associated with podosome-like structures on mesodermal progenitor cells. 222
Expression of MDR1, MRP, TOPOISOMERASE-IIa, TOPOISOMERASE-IIb and GSTp in acute leukemias. 221
Human autologous plasma-derived clot as a biological scaffold for mesenchymal stem cells in treatment of orthopedic healing. 219
Novel biological/biohybrid prostheses for the ossicular chain: fabrication feasibility and preliminary functional characterization 219
A rare case of de novo CD5+ diffuse large B-cell lymphoma in leukemic phase and positive for CD13 218
1,25-Dihydroxyvitamin D3-mediated inhibition of human leukemic B cell precursors 217
MESENCHYMAL CELLS INHIBIT IL2 AND ZOLENDRONATE-INDUCED ?/d T-LYMPHOCYTES 217
Association of the hOCT1/ABCB1 genotype with efficacy and tolerability of imatinib in patients affected by chronic myeloid leukemia 217
CHEMOIMMUNOTHERAPY REGIMEN OF FLUDARABINE, CYCLOPHOSPHAMIDE, AND RITUXIMAB FOLLOWED BY ALEMTUZUM- AB AS INITIAL THERAPY FOR CHRONIC LYMPHOCYTIC LEUKAEMIA: A VALID APPROACH FOR ERADICATION OF MINIMAL RESIDUAL DISEASE 216
Processing large-diameter poly(L-lactic acid) microfiber mesh/mesenchymal stromal cell constructs via resin embedding: an efficient histologic method 216
Infliximab treatment of grade IV skin acute graft versus host disease 215
Investigation of interactions between poly-L-lysine-coated boron nitride nanotubes and C2C12 cells: up-take, cytocompatibility, and differentiation 215
Treatment of oral mucositis in hematologic patients undergoing autologous or allogeneic transplantation of peripheral blood stem cells: a prospective, randomized study with a mouthwash containing Camelia Sinensis leaf extract 214
Growing bone tissue-engineered niches with graded osteogenicity: an in vitro method for biomimetic construct assembly 214
Low-dose ARA-C and 1(OH) D3 administration in acute non lymphoid leukemia: pilot study. 213
The hOCT1 and ABCB1 polymorphisms do not influence the pharmacodynamics of nilotinib in chronic myeloid leukemia 213
Vitamin D binding protein is produced by human monocytes 212
Tympanic Membrane Collagen Expression by Dynamically Cultured Human Mesenchymal Stromal Cell/Star-Branched Poly(ε-Caprolactone) Nonwoven Constructs 212
Quantitative molecular monitoring of BCR-ABL and MDR1 transcripts in patients with chronic myeloid leukemia during Imatinib treatment 212
Could age modify the effect of genetic variants in IL6 and TNF-a genes in multiple myeloma? 211
CD229 expression on bone marrow plasma cells from patients with multiple myeloma and monoclonal gammopathies of uncertain significance 211
Mesangiogenic Progenitor Cells Derived from One Novel CD64brightCD31brightCD14neg Population in Human Adult Bone Marrow 211
Constitutive expression of pluripotency-associated genes in mesodermal progenitor cells (MPCs) 211
Autoimmune diseases and myeloid hematological disorders: a possible pathogenetic relationship 211
INTRA-LYMPHOCYTIC ADENOSINE-DEAMINASE AND PURINE NUCLEOSIDE PHOSPHORYLASE-ACTIVITY IN CHRONIC LYMPHOCYTIC-LEUKEMIA - EFFECT OF THYMOSTIMULIN 210
Comprehensive investigation of genetic variation in the 8q24 region and multiple myeloma risk in the IMMEnSE consortium. 210
Alteraciones funcionales de los granulocitos neutrofilos en un joven neutropenico de raza negra 208
Nonpegylated liposomal doxorubicin (MyocetTM) combination (R-COMP) chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL): results from the phase II EUR018 trial 208
Activity of different revertant agents on multidrug resistance: in vitro evaluation of their combination 208
β-Cell inflammation in human type 2 diabetes and the role of autophagy 208
Immunomodulators and enzymes of purine metabolism in human lymphocytes 207
Adenosine deaminase activity in human cord blood lymphocyte subpopulations. 206
Binding of GC (VDBP) to membranes of human B lymphocytes following stripping of extant protein. 206
EFFICACY OF FLUDARABINE, CYCLOPHOSPHAMIDE, RITUXIMAB (FCR) REGIMEN FOL- LOWED BY ALEMTUZUMAB AS IN VIVO PURGING TOOL FOR PATIENTS WITH ADVANCED CHRONIC LYMPHOCYTIC LEUKEMIA 206
WT1 GENE EXPRESSION IS SIGNIFICANTLY INHIBITED BY VORINOSTAT AND BORTEZOMIB IN MYELOPROLIFERATIVE/MYELODISPLASTIC DISEASES 206
La storia della Facoltà di Medicina e Chirurgia 206
Preparation of stable dispersion of barium titanate nanoparticles: Potential applications in biomedicine 206
Response to chemotherapy and tandem autologous transplantation of multiple myeloma patients and GSTP1 and TYMS polymorphisms 205
Modifications in B-Lymphocyte Number and Phenotype in the Course of Pregnancy in a Woman with Persistent Polyclonal B-Cell Lymphocytosis: A Flow Cytometric Study 205
Complex translocation t(3;9;22)(q21;q34;q11) at diagnosis is a negative prognostic index in chronic myeloid leukemia. 204
EXTENSIVE ANALYSIS OF T CELL RECEPTOR GAMMA (TCRG) GENE REARRANGEMENTS REVEALS A SIMILAR REPERTOIRE IN EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (EGPA) AND IN HYPEREOSINOPHILIC SYNDROME (HES) 204
Boron nitride nanotubes and primary human osteoblasts: in vitro compatibility and biological interactions under low frequency ultrasound stimulation 204
Mesodermal progenitor cells (MPCs) differentiate into mesenchymal stromal cells (MSCs) by activation of Wnt5/calmodulin signalling pathway. 203
Reversing of chlorambucil resistance by ethacrynic acid in a B-CLL patient 202
Genetics and molecular epidemiology of multiple myeloma: the rationale for the IMMEnSE consortium (review). 202
Human dental pulp stem cells protect mouse dopaminergic neurons against MPP+ or rotenone. 202
HOX and TALE signatures specify human stromal stem cell populations from different sources. 202
Evaluation of the MDR1, ABCG2, Topoisomerases IIalpha and GSTpi gene expression in patients affected by aggressive mantle cell lymphoma treated by the R-Hyper-CVAD regimen 201
The c.480C>G polymorphism of hOCT1 influences imatinib clearance in patients affected by chronic myeloid leukemia. 201
The effects of lithium and rubidium on human leukocyte functions 200
Type 2 diabetes-related variants influence the risk of developing multiple myeloma: results from the IMMEnSE consortium. 200
Dipeptidyl-Peptidase 4 (Cd26): a Possible Therapeutic Target in Covid-19 200
Phenotypic markers in chronic lymphocytic leukemia. 198
Expression of p170 protein in multiple myeloma : a clinical study 198
Correction: Use of Autologous Human mesenchymal Stromal Cell/Fibrin Clot Constructs in Upper Limb Non-Unions: Long-Term Assessment. 198
The combination of rituximab and bendamustine as first-line treatment is highly effective in the eradicating minimal residual disease in follicular lymphoma: An Italian retrospective study 198
NEUROENDOCRINE MODULATION OF ALLOGRAFT REJECTION BY DOPAMINE AGONISTS 197
Oral cyclophosphamide therapy for patients with residual or relapsed indolent-type lymphoma after initial treatment for aggressive lymphomas. A sub-group of patients with apparent transformed indolent lymphoma. 197
Development of tissue-engineered substitutes of the ear ossicles: PORP-shaped poly(propylene fumarate)-based scaffolds cultured with human mesenchymal stromal cells. 197
Arsenic trioxide and ascorbic acid interfere with the BCL2 family genes in patients with myelodysplastic syndromes: an ex-vivo study. 197
Multiple small bowel perforations due to invasive aspergillosis in a patient with acute myeloid leukemia: case report and a systematic review of the literature 197
Combined unfavourable polymorphisms ofhOCT1 and ABCG2 are responsible for delayed complete cytogenetic response during imatinib treatment. 197
Modulation of glycoprotein P in the primary culture of rat hepatocytes 196
A case of Staphylococcal toxic shock syndrome with expansion of TCR alphaBeta+, CD4/CD8 double negative lymphocytes 196
Carboxy-terminal fragment of osteogenic growth peptide regulates myeloid differentiation through RhoA 196
Human dental pulp stem cells protect mouse dopaminergic neurons against MPP+ or rotenone 196
Combination of CD157 and FLAER to Detect Peripheral Blood Eosinophils by Multiparameter Flow Cytometry 196
In vivo and in vitro effects of thymostimulin (TP-1) on immunodeficiencies 195
Enhancement of neurite outgrowth in neuronal-like cells following boron nitride nanotube-mediated stimulation 195
Synergistic effects of alpha interferon and 1,25 dihydroxyvitamin D3: Preliminary evidence suggesting that interferon induces expression of the vitamin receptor 194
Totale 24.940
Salva come PNG Salva come JPEG
Categoria #
all - tutte 262.274
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 262.274
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.361 0 0 0 0 0 0 0 0 0 0 427 934
2021/20227.322 158 425 209 573 1.359 938 183 326 353 184 563 2.051
2022/20238.885 1.206 1.188 606 827 963 1.190 82 718 1.404 40 585 76
2023/20249.722 933 768 836 449 996 1.136 217 176 90 3.378 136 607
2024/202519.171 68 711 138 1.194 1.841 1.827 1.577 1.080 1.826 2.571 2.059 4.279
2025/202618.887 1.227 2.568 2.228 1.553 1.992 2.010 3.077 889 969 1.869 505 0
Totale 100.719